Skip to main content

Main menu

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
  • Submit
  • About
    • Editorial Board
    • PNAS Staff
    • FAQ
    • Accessibility Statement
    • Rights and Permissions
    • Site Map
  • Contact
  • Journal Club
  • Subscribe
    • Subscription Rates
    • Subscriptions FAQ
    • Open Access
    • Recommend PNAS to Your Librarian

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Home
Home
  • Log in
  • My Cart

Advanced Search

  • Home
  • Articles
    • Current
    • Special Feature Articles - Most Recent
    • Special Features
    • Colloquia
    • Collected Articles
    • PNAS Classics
    • List of Issues
  • Front Matter
    • Front Matter Portal
    • Journal Club
  • News
    • For the Press
    • This Week In PNAS
    • PNAS in the News
  • Podcasts
  • Authors
    • Information for Authors
    • Editorial and Journal Policies
    • Submission Procedures
    • Fees and Licenses
  • Submit
This Week in PNAS

In This Issue

PNAS August 12, 2008 105 (32) 11033-11034; https://doi.org/10.1073/iti03208105
  • Article
  • Figures & SI
  • Info & Metrics
  • PDF
Loading

BIOCHEMISTRY

Injected vitamin C slows tumor growth

Ascorbate, or vitamin C, is usually thought of as an antioxidant. The body tightly controls blood levels of orally ingested ascorbate, capping them at 0.2 mM.However, Qi Chen et al. show that injection can circumvent this limit, allowing pharmacological concentrations up to 30 mM, which exert an oxidative effect and slow tumor growth. A previous study suggested that ascorbate might be effective against terminal cancer, but a subsequent trial appeared to show that ascorbate had no effect. Later research revealed the tight constraints on orally ingested ascorbate and provided the rationale for the present work. The authors first tested a range of tumor and normal cell lines, showing that the ascorbate EC50 for most tumor lines was <10 mM, whereas normal cells easily tolerate >20 mM. The authors then demonstrated ascorbate's protective effects in a mouse tumor model, showing that ascorbate slowed tumor growth by 43–51% in three types of aggressive tumors. Because clinical investigation revealed that plasma levels of ascorbate reached in human patients are similar to those achieved in the mice, the authors suggest that ascorbate may prove to be a useful component of an anticancer regimen. — K.M.

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Proposed mechanism for tumoricidal action of ascorbate (AA).

“Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice” by Qi Chen, Michael Graham Espey, Andrew Y. Sun, Chaya Pooput, Kenneth L. Kirk, Murali C. Krishna, Deena Beneda Khosh, Jeanne Drisko, and Mark Levine (see pages 11105–11109)

IMMUNOLOGY

West Nile virus treatment increases survival

Transmitted by mosquitoes, the West Nile virus is now endemic to regions of North America and causes hundreds of deaths annually in humans. No vaccine exists for the virus, which can result in a fatal encephalitis in elderly and immunocompromised individuals. Erin McCandless et al. developed a treatment that spurs the immune system to clear West Nile from the central nervous system. The authors continuously infused infected mice with AMD3100, also known as Plerixafor, which was initially developed to treat HIV infection. The molecule works by blocking the chemokine receptor CXCR4. Typically, this receptor binds the CXCL12 chemokine on immune cells, and the interaction sequesters the cells into perivascular spaces, preventing them from crossing the blood–brain barrier. By blocking CXCR4 in infected mice, the authors freed T cells from breaching the blood–brain barrier, which allowed the cells to clear the viral infection from the central nervous system. Treated animals recovered 8 days after infection, whereas untreated mice continued to sicken and died. The authors suggest that their results may point to a method for treating West Nile infection and other forms of viral encephalitis. — F.A.

Figure2
  • Download figure
  • Open in new tab
  • Download powerpoint

AMD3100 enhances T cells (red) to clear West Nile virus infection (green).

“CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis” by Erin E. McCandless, Bo Zhang, Michael S. Diamond, and Robyn S. Klein (see pages 11270–11275)

MEDICAL SCIENCES

Modeling TB culture and drug susceptibility testing

South Africa has one of the world's highest burdens of tuberculosis (TB), including multidrug-resistant (MDR) and extensively drug-resistant (XDR) strains. The gold standard for TB diagnosis is growth of the bacillus in culture, but estimates show that this test is applied to only ≈5% of new cases. David Dowdy et al. developed a quantitative model to investigate the benefits of expanding culture and drug susceptibility testing to a larger fraction of South Africa's TB patients over a 10-year period. The authors found substantial benefit from the expanded testing, at a reasonable cost, provided the new regime is initiated immediately. They considered eight scenarios, each with variations in the proportion of patients tested and the time of program onset. Their model showed that if culture and drug susceptibility tests are applied to 37% of new patients and to 85% of patients whose first round of treatment was unsuccessful, then ≈48,000 lives will be saved and 60,000 TB cases averted—including 7,700 MDR cases—of the estimated 2 million TB cases that are likely to develop in South Africa over the next 10 years. However, this strategy will not reduce the incidence of XDR-TB unless transmission is also inhibited, the authors say. — K.M.

“Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing” by David W. Dowdy, Richard E. Chaisson, Gary Maartens, Elizabeth L. Corbett, and Susan E. Dorman (see pages 11293–11298)

MICROBIOLOGY

Nicotinic acid metabolism deciphered

José Jiménez et al. report the complete set of genes required for aerobic nicotinic acid (vitamin B3) degradation. Their findings reveal details of an important metabolic pathway for the detoxification and biotransformation of many N-heterocyclic aromatic compounds, including pyridine cofactors such as NAD and NADP, toxic hydroxypyridines, and alkaloids such as nicotine and anabasine. The authors found that some of the proteins used by Pseudomonas putida to degrade nicotinic acid have unique structures and mechanisms. For example, the first step in degradation involves the hydroxylation of nicotinic acid to 6-hydroxynicotinic acid, which is catalyzed by a two-component hydroxylase, NicAB, which represents a unique class of xanthine dehydrogenases. An iron-dependent dioxygenase called NicX then converts 2,5-dihydroxypyridine to N-formylmaleamic acid. The authors say NicX is the founding member of a previously unreported family of extradiol ring-cleavage dioxygenases that evolved from metalloproteases, with no relationship to other dioxygenase enzymes. Further conversions catalyzed by NicD—the first α/β hydrolase with deformylase activity—yield NicE and NicF proteins that ultimately produce ammonium ion, formic acid, and fumaric acid. The authors suggest that similar genes in other saprophytic bacteria and pathogens may play a role in virulence. — P.D.

Figure3
  • Download figure
  • Open in new tab
  • Download powerpoint

Structure of NicX, the first member of a newly identified family of dioxygenases.

“Deciphering the genetic determinants for aerobic nicotinic acid degradation: The nic cluster from Pseudomonas putida KT2440” by José I. Jiménez, Ángeles Canales, Jesús Jiménez-Barbero, Krzysztof Ginalski, Leszek Rychlewski, José L. García, and Eduardo Díaz (see pages 11329–11334)

PreviousNext
Back to top
Article Alerts
Email Article

Thank you for your interest in spreading the word on PNAS.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
In This Issue
(Your Name) has sent you a message from PNAS
(Your Name) thought you would like to see the PNAS web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
In This Issue
Proceedings of the National Academy of Sciences Aug 2008, 105 (32) 11033-11034; DOI: 10.1073/iti03208105

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Request Permissions
Share
In This Issue
Proceedings of the National Academy of Sciences Aug 2008, 105 (32) 11033-11034; DOI: 10.1073/iti03208105
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Mendeley logo Mendeley

Related Articles

  • Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice
    - Aug 04, 2008
  • Deciphering the genetic determinants for aerobic nicotinic acid degradation: The nic cluster from Pseudomonas putida KT2440
    - Aug 04, 2008
  • CXCR4 antagonism increases T cell trafficking in the central nervous system and improves survival from West Nile virus encephalitis
    - Aug 04, 2008
  • Impact of enhanced tuberculosis diagnosis in South Africa: A mathematical model of expanded culture and drug susceptibility testing
    - Aug 11, 2008
Proceedings of the National Academy of Sciences: 105 (32)
Table of Contents

Submit

Sign up for Article Alerts

Jump to section

  • Article
    • BIOCHEMISTRY
    • IMMUNOLOGY
    • MEDICAL SCIENCES
    • MICROBIOLOGY
  • Figures & SI
  • Info & Metrics
  • PDF

You May Also be Interested in

Setting sun over a sun-baked dirt landscape
Core Concept: Popular integrated assessment climate policy models have key caveats
Better explicating the strengths and shortcomings of these models will help refine projections and improve transparency in the years ahead.
Image credit: Witsawat.S.
Model of the Amazon forest
News Feature: A sea in the Amazon
Did the Caribbean sweep into the western Amazon millions of years ago, shaping the region’s rich biodiversity?
Image credit: Tacio Cordeiro Bicudo (University of São Paulo, São Paulo, Brazil), Victor Sacek (University of São Paulo, São Paulo, Brazil), and Lucy Reading-Ikkanda (artist).
Syrian archaeological site
Journal Club: In Mesopotamia, early cities may have faltered before climate-driven collapse
Settlements 4,200 years ago may have suffered from overpopulation before drought and lower temperatures ultimately made them unsustainable.
Image credit: Andrea Ricci.
Steamboat Geyser eruption.
Eruption of Steamboat Geyser
Mara Reed and Michael Manga explore why Yellowstone's Steamboat Geyser resumed erupting in 2018.
Listen
Past PodcastsSubscribe
Birds nestling on tree branches
Parent–offspring conflict in songbird fledging
Some songbird parents might improve their own fitness by manipulating their offspring into leaving the nest early, at the cost of fledgling survival, a study finds.
Image credit: Gil Eckrich (photographer).

Similar Articles

Site Logo
Powered by HighWire
  • Submit Manuscript
  • Twitter
  • Facebook
  • RSS Feeds
  • Email Alerts

Articles

  • Current Issue
  • Special Feature Articles – Most Recent
  • List of Issues

PNAS Portals

  • Anthropology
  • Chemistry
  • Classics
  • Front Matter
  • Physics
  • Sustainability Science
  • Teaching Resources

Information

  • Authors
  • Editorial Board
  • Reviewers
  • Subscribers
  • Librarians
  • Press
  • Site Map
  • PNAS Updates
  • FAQs
  • Accessibility Statement
  • Rights & Permissions
  • About
  • Contact

Feedback    Privacy/Legal

Copyright © 2021 National Academy of Sciences. Online ISSN 1091-6490